Literature DB >> 28736342

TFOS DEWS II Diagnostic Methodology report.

James S Wolffsohn1, Reiko Arita2, Robin Chalmers3, Ali Djalilian4, Murat Dogru5, Kathy Dumbleton6, Preeya K Gupta7, Paul Karpecki8, Sihem Lazreg9, Heiko Pult10, Benjamin D Sullivan11, Alan Tomlinson12, Louis Tong13, Edoardo Villani14, Kyung Chul Yoon15, Lyndon Jones16, Jennifer P Craig17.   

Abstract

The role of the Tear Film and Ocular Surface Society (TFOS) Dry Eye Workshop (DEWS) II Diagnostic Methodology Subcommittee was 1) to identify tests used to diagnose and monitor dry eye disease (DED), 2) to identify those most appropriate to fulfil the definition of DED and its sub-classifications, 3) to propose the most appropriate order and technique to conduct these tests in a clinical setting, and 4) to provide a differential diagnosis for DED and distinguish conditions where DED is a comorbidity. Prior to diagnosis, it is important to exclude conditions that can mimic DED with the aid of triaging questions. Symptom screening with the DEQ-5 or OSDI confirms that a patient might have DED and triggers the conduct of diagnostic tests of (ideally non-invasive) breakup time, osmolarity and ocular surface staining with fluorescein and lissamine green (observing the cornea, conjunctiva and eyelid margin). Meibomian gland dysfunction, lipid thickness/dynamics and tear volume assessment and their severity allow sub-classification of DED (as predominantly evaporative or aqueous deficient) which informs the management of DED. Videos of these diagnostic and sub-classification techniques are available on the TFOS website. It is envisaged that the identification of the key tests to diagnose and monitor DED and its sub-classifications will inform future epidemiological studies and management clinical trials, improving comparability, and enabling identification of the sub-classification of DED in which different management strategies are most efficacious.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DEWS; Diagnosis; Dry Eye Workshop; Dry eye disease (DED); Methodology; Monitoring; Questionnaires; Sub-classification of dry eye; Tests for dry eye

Mesh:

Substances:

Year:  2017        PMID: 28736342     DOI: 10.1016/j.jtos.2017.05.001

Source DB:  PubMed          Journal:  Ocul Surf        ISSN: 1542-0124            Impact factor:   5.033


  289 in total

1.  Dry Eye Assessment and Management (DREAM©) Study: Study design and baseline characteristics.

Authors:  Penny A Asbell; Maureen G Maguire; Ellen Peskin; Vatinee Y Bunya; Eric J Kuklinski
Journal:  Contemp Clin Trials       Date:  2018-06-06       Impact factor: 2.226

2.  Comprehensive Clinical, Diagnostic, and Advanced Imaging Characterization of the Ocular Surface in Spontaneous Aqueous Deficient Dry Eye Disease in Dogs.

Authors:  Brian C Leonard; Kathleen A Stewart; Gillian C Shaw; Alyssa L Hoehn; Amelia A Stanley; Christopher J Murphy; Sara M Thomasy
Journal:  Cornea       Date:  2019-12       Impact factor: 2.651

3.  [Diagnosis of dry eye disease].

Authors:  C Jacobi; E M Messmer
Journal:  Ophthalmologe       Date:  2018-05       Impact factor: 1.059

4.  Comparative portrayal of ocular surface microbe with and without dry eye.

Authors:  ZhenHao Li; Yufang Gong; ShuZe Chen; SiQi Li; Yu Zhang; HuiMin Zhong; ZhouCheng Wang; YiFan Chen; QiXin Deng; YuTing Jiang; LiYing Li; Min Fu; GuoGuo Yi
Journal:  J Microbiol       Date:  2019-08-28       Impact factor: 3.422

5.  Meibomian glands visibility assessment through a new quantitative method.

Authors:  José Vicente García-Marqués; Santiago García-Lázaro; Noelia Martínez-Albert; Alejandro Cerviño
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-01-06       Impact factor: 3.117

6.  Repeatability of Non-invasive Keratograph Break-Up Time measurements obtained using Oculus Keratograph 5M.

Authors:  José Vicente García-Marqués; Noelia Martínez-Albert; Cristian Talens-Estarelles; Santiago García-Lázaro; Alejandro Cerviño
Journal:  Int Ophthalmol       Date:  2021-03-16       Impact factor: 2.031

7.  Comparative Evaluation of Clinical Methods of Tear Film Stability Assessment: A Randomized Crossover Trial.

Authors:  Michael T M Wang; Jennifer P Craig
Journal:  JAMA Ophthalmol       Date:  2018-03-01       Impact factor: 7.389

8.  Clusterin from human clinical tear samples: Positive correlation between tear concentration and Schirmer strip test results.

Authors:  Valerie Yu; Dhruva Bhattacharya; Andrew Webster; Aditi Bauskar; Charles Flowers; Martin Heur; Shravan K Chintala; Tatsuo Itakura; Mark R Wilson; Joseph T Barr; Shinwu Jeong; Mingwu Wang; M Elizabeth Fini
Journal:  Ocul Surf       Date:  2018-08-02       Impact factor: 5.033

Review 9.  Ocular Graft-versus-Host Disease after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation.

Authors:  Yoshihiro Inamoto; Nuria Valdés-Sanz; Yoko Ogawa; Monica Alves; Luigi Berchicci; John Galvin; Hildegard Greinix; Gregory A Hale; Biljana Horn; Debra Kelly; Hien Liu; Scott Rowley; Helene Schoemans; Ami Shah; Maria Teresa Lupo Stanghellini; Vaibhav Agrawal; Ibrahim Ahmed; Asim Ali; Neel Bhatt; Michael Byrne; Saurabh Chhabra; Zachariah DeFilipp; Kristina Fahnehjelm; Nosha Farhadfar; Erich Horn; Catherine Lee; Sunita Nathan; Olaf Penack; Pinki Prasad; Seth Rotz; Alicia Rovó; Jean Yared; Steven Pavletic; Grzegorz W Basak; Minoo Battiwalla; Rafael Duarte; Bipin N Savani; Mary E D Flowers; Bronwen E Shaw; Igor Petriček
Journal:  Biol Blood Marrow Transplant       Date:  2018-11-24       Impact factor: 5.742

10.  Crosslinked hyaluronic acid with liposomes and crocin for management symptoms of dry eye disease caused by moderate meibomian gland dysfunction.

Authors:  José-María Sánchez-González; Concepción De-Hita-Cantalejo; María Carmen Sánchez-González
Journal:  Int J Ophthalmol       Date:  2020-09-18       Impact factor: 1.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.